Broadridge Financial Solutions (NYSE:BR) Given “Outperform” Rating at Royal Bank of Canada
Royal Bank of Canada reiterated their outperform rating on shares of Broadridge Financial Solutions (NYSE:BR – Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a $246.00 target price on the business services provider’s stock. BR has been the subject of several other reports. Morgan Stanley lifted their […]
Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Consensus Recommendation of “Hold” from Brokerages
Fortrea Holdings Inc. (NASDAQ:FTRE – Get Free Report) has earned an average rating of “Hold” from the twelve analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, eight have issued a hold rating, two have given a buy rating and one has assigned a strong buy […]
Centuri (NYSE:CTRI) Price Target Raised to $17.00 at JPMorgan Chase & Co.
Centuri (NYSE:CTRI – Get Free Report) had its price target upped by equities research analysts at JPMorgan Chase & Co. from $16.00 to $17.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s target price points to a […]
Starwood Property Trust (NYSE:STWD) Price Target Cut to $20.00 by Analysts at JPMorgan Chase & Co.
Starwood Property Trust (NYSE:STWD – Get Free Report) had its price target reduced by JPMorgan Chase & Co. from $20.50 to $20.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the real estate investment trust’s stock. JPMorgan Chase & Co.‘s price target points to a potential […]
Neumora Therapeutics (NASDAQ:NMRA) Stock Rating Lowered by JPMorgan Chase & Co.
Neumora Therapeutics (NASDAQ:NMRA – Get Free Report) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a note issued to investors on Tuesday, Marketbeat.com reports. They presently have a $15.00 price objective on the stock, down from their prior price objective of $18.00. JPMorgan Chase & […]
Nektar Therapeutics (NASDAQ:NKTR) Receives $2.33 Consensus Price Target from Analysts
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average recommendation of “Hold” from the seven brokerages that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company. The average twelve-month […]
Kite Realty Group Trust (NYSE:KRG) Sets New 52-Week High – Here’s Why
Kite Realty Group Trust (NYSE:KRG – Get Free Report) shares reached a new 52-week high on Wednesday . The stock traded as high as $27.94 and last traded at $27.28, with a volume of 71212 shares. The stock had previously closed at $26.87. Analyst Upgrades and Downgrades A number of research firms recently issued reports […]
Sixth Street Specialty Lending (NYSE:TSLX) Rating Increased to Buy at LADENBURG THALM/SH SH
Sixth Street Specialty Lending (NYSE:TSLX – Get Free Report) was upgraded by investment analysts at LADENBURG THALM/SH SH from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, MarketBeat Ratings reports. The firm presently has a $21.00 price objective on the financial services provider’s stock. LADENBURG THALM/SH SH’s price objective […]
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Consensus Recommendation of “Buy” by Analysts
Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) have received an average recommendation of “Buy” from the seven ratings firms that are covering the stock, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have covered the stock in the last […]
last updated on 7 Nov 20:47